The novel RASSF6 and RASSF10 candidate tumour suppressor genes are frequently epigenetically inactivated in childhood leukaemias

BackgroundThe Ras-assocation family (RASSF) of tumour suppressor genes (TSGs) contains 10 members that encode proteins containing Ras-assocation (RA) domains. Several members of the RASSF family are frequently epigenetically inactivated in cancer, however, their role in leukaemia has remained largely uninvestigated. Also, RASSF10 is a predicted gene yet to be experimentally verified. Here we cloned, characterised and demonstrated expression of RASSF10 in normal human bone marrow. We also determined the methylation status of CpG islands associated with RASSF1–10 in a series of childhood acute lymphocytic leukaemias (ALL) and normal blood and bone marrow samples.ResultsCOBRA and bisulphite sequencing revealed RASSF6 and RASSF10 were the only RASSF members with a high frequency of leukaemia-specific methylation. RASSF6 was methylated in 94% (48/51) B-ALL and 41% (12/29) T-ALL, whilst RASSF10 was methylated in 16% (8/51) B-ALL and 88% (23/26) T-ALL. RASSF6 and RASSF10 expression inversely correlated with methylation which was restored by treatment with 5-aza-2'deoxycytidine (5azaDC).ConclusionThis study shows the hypermethylation profile of RASSF genes in leukaemias is distinct from that of solid tumours and represents the first report of inactivation of RASSF6 or RASSF10 in cancer. These data show epigenetic inactivation of the candidate TSGs RASSF6 and RASSF10 is an extremely frequent event in the pathogenesis of childhood leukaemia. This study also warrants further investigation of the newly identified RASSF member RASSF10 and its potential role in leukaemia.

[1]  L. Hesson,et al.  The RASSF1A Tumor Suppressor Activates Bax via MOAP-1* , 2006, Journal of Biological Chemistry.

[2]  Walter Kolch,et al.  RASSF1A elicits apoptosis through an MST2 pathway directing proapoptotic transcription by the p73 tumor suppressor protein. , 2007, Molecular cell.

[3]  J. Downward.  Targeting RAS signalling pathways in cancer therapy , 2003, Nature Reviews Cancer.

[4]  M. Kozak.  Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes , 1986, Cell.

[5]  J. Posakony,et al.  Genetic programs activated by proneural proteins in the developing Drosophila PNS. , 2005, Developmental cell.

[6]  G. Pfeifer,et al.  The RASSF proteins in cancer; from epigenetic silencing to functional characterization. , 2009, Biochimica et biophysica acta.

[7]  David J. Adams,et al.  The Ras-association domain family (RASSF) members and their role in human tumourigenesis , 2007, Biochimica et biophysica acta.

[8]  L. Hesson,et al.  RASSF6 is a novel member of the RASSF family of tumor suppressors , 2007, Oncogene.

[9]  B. Neel,et al.  The tumor suppressor RASSF1A and MAP-1 link death receptor signaling to Bax conformational change and cell death. , 2005, Molecular cell.

[10]  N. Perrimon,et al.  A genome-wide RNA interference screen in Drosophila melanogaster cells for new components of the Hh signaling pathway , 2005, Nature Genetics.

[11]  K. Hoang-Xuan,et al.  Frequent epigenetic inactivation of RASSF1A and BLU genes located within the critical 3p21.3 region in gliomas , 2004, Oncogene.

[12]  L. Hesson,et al.  The Role of RASSF1A Methylation in Cancer , 2007, Disease markers.

[13]  S. Selvin,et al.  RAS mutation is associated with hyperdiploidy and parental characteristics in pediatric acute lymphoblastic leukemia , 2005, Leukemia.

[14]  J. Avruch,et al.  Regulation of the MST1 kinase by autophosphorylation, by the growth inhibitory proteins, RASSF1 and NORE1, and by Ras. , 2004, The Biochemical journal.

[15]  L. Hesson,et al.  CpG island promoter hypermethylation of a novel Ras-effector gene RASSF2A is an early event in colon carcinogenesis and correlates inversely with K-ras mutations , 2005, Oncogene.

[16]  Y. Hata,et al.  Ras-association domain family protein 6 induces apoptosis via both caspase-dependent and caspase-independent pathways. , 2007, Experimental cell research.

[17]  F. Latif,et al.  Role of the Ras-association domain family 1 tumor suppressor gene in human cancers. , 2005, Cancer research.

[18]  L. Hesson,et al.  RASSF4/AD037 Is a Potential Ras Effector/Tumor Suppressor of the RASSF Family , 2004, Cancer Research.

[19]  R. Xavier,et al.  Identification of a Novel Ras-Regulated Proapoptotic Pathway , 2002, Current Biology.

[20]  Walter Kolch,et al.  Role of the Kinase MST2 in Suppression of Apoptosis by the Proto-Oncogene Product Raf-1 , 2004, Science.

[21]  M. Kozak,et al.  Interpreting cDNA sequences: Some insights from studies on translation , 1996, Mammalian Genome.

[22]  Jen-Fen Fu,et al.  K‐ras mutations and N‐ras mutations in childhood acute leukemias with or without mixed‐lineage leukemia gene rearrangements , 2006, Cancer.

[23]  A. Chalmers,et al.  RASSF7 is a member of a new family of RAS association domain-containing proteins and is required for completing mitosis. , 2008, Molecular biology of the cell.

[24]  B. Johansson,et al.  Mutations of FLT3, NRAS, KRAS, and PTPN11 are frequent and possibly mutually exclusive in high hyperdiploid childhood acute lymphoblastic leukemia , 2008, Genes, chromosomes & cancer.